FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIMPAT (lacosamide) submitted by UCB, Inc. The action updates the product labeling with the new or expanded indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

SUPPL AP for VIMPAT (LACOSAMIDE)